Prevalence of the RAPGEF5 c.2624C>A and PLOD1 c.2032G>A variants associated with equine familial isolated hypoparathyroidism and fragile foal syndrome in the US Thoroughbred population (1988-2019)

被引:1
|
作者
Elcombe, Megan E. [1 ,2 ]
Bellone, Rebecca R. [1 ,2 ]
Magdesian, K. Gary [3 ]
Finno, Carrie J. [1 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Davis, CA 95616 USA
[3] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
关键词
equine familial isolated hypoparathyroidism; fragile foal syndrome; genetic testing; horse; PLOD1; RAPGEF5; Thoroughbred;
D O I
10.1111/evj.13883
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Equine familial isolated hypoparathyroidism (EFIH) and fragile foal syndrome (FFS) are both fatal recessive conditions reported in Thoroughbred foals. The causal variants for EFIH (RAPGEF5 c.2624C>A; EquCab3.0. chr4: g.54108297G>T) and FFS (PLOD1 c.2032G>A; EquCab3.0, chr2: g.39927817) were recently reported. Prevalence assessment for these variants in a large cohort of samples is needed to provide evidence-based recommendations for genetic testing. Objectives To estimate the frequency of the EFIH and FFS variant alleles in the United States Thoroughbred population between 1988 and 2019, and determine whether these are recent mutations or are increasing in frequency due to current breeding practices. Study design Population allele frequency study. Methods Genomic DNA from hair and serum samples were genotyped for the EFIH and FFS. Allele frequencies between cohorts, based on year of birth (1988-2000, n = 728) and (2001-2019, n = 1059), as well as across the seven geographical regions of the United States were compared by Fisher's Exact tests. Results EFIH and FFS allele frequencies were not significantly different between the two time points studied (0.008 and 0.004, respectively, in the older cohorts and 0.008 and 0.009 in most recent years). No EFIH or FFS homozygotes were detected. A sample from 1992 was identified as a carrier for EFIH and one from 1993 a carrier for FFS. Non-significant changes in geographical distribution of carriers for both traits were observed. Main limitations The earliest samples available for study were from foals born in 1988. Conclusions The EFIH and FFS variants are present at low frequency in the United States Thoroughbred population but are not recent mutations. There is no evidence to support changes in allele frequency over time. However, given the closed studbook and breeding practices, continued monitoring of breed allele frequencies and genetic testing is recommended to avoid the mating of carriers and production of affected foals.
引用
收藏
页码:666 / 671
页数:6
相关论文
共 4 条
  • [1] Fragile Foal Syndrome (PLOD1 c.2032G>A) occurs across diverse horse populations
    Martin, Katie
    Brooks, Samantha
    Vierra, Micaela
    Lafayette, W. Tyler
    McClure, Scott
    Carpenter, Meredith
    Lafayette, Christa
    [J]. ANIMAL GENETICS, 2021, 52 (01) : 137 - 138
  • [2] First reported case of fragile foal syndrome type 1 in the Thoroughbred caused by PLOD1 c.2032G>A
    Grillos, Alexandra S.
    Roach, Jessica M.
    de Mestre, Amanda M.
    Foote, Alastair K.
    Kinglsey, Nicole B.
    Mienaltowski, Michael J.
    Bellone, Rebecca R.
    [J]. EQUINE VETERINARY JOURNAL, 2022, 54 (06) : 1086 - 1093
  • [3] Hanoverian F/W-line contributes to segregation of Warmblood fragile foal syndrome type 1 variant PLOD1:c.2032G>A in Warmblood horses
    Metzger, Julia
    Kreft, Oliver
    Sieme, Harald
    Martinsson, Gunilla
    Reineking, Wencke
    Hewicker-Trautwein, Marion
    Distl, Ottmar
    [J]. EQUINE VETERINARY JOURNAL, 2021, 53 (01) : 51 - 59
  • [4] Warmblood fragile foal syndrome type 1 mutation (PLOD1 c.2032G>A) is not associated with catastrophic breakdown and has a low allele frequency in the Thoroughbred breed
    Bellone, R. R.
    Ocampo, N. R.
    Hughes, S. S.
    Le, V
    Arthur, R.
    Finno, C. J.
    Penedo, M. C. T.
    [J]. EQUINE VETERINARY JOURNAL, 2020, 52 (03) : 411 - 414